EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:EndoGastric Solutions Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014100
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesophageal valve. EGS’ products are also used to perform transoral incisionless fundoplication. The company’s serosa-fuse fasteners are deployed using EsophyX devices to facilitate esophagogastric tissue plications. Its products provide solutions for hospital stay, reduced patient discomfort, faster patient recovery and patient satisfaction programs. The company develops natural orifice surgical products and procedures to treat gastrointestinal diseases. EGS is headquartered in Redmond, Washington, the US.

EndoGastric Solutions Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
EndoGastric Solutions Inc, Medical Devices Deals, 2011 to YTD 2017 9
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
EndoGastric Solutions Raises USD50 Million in Financing Round 11
Endogastric Solutions Raises US$30 Million In Series G Venture Financing 13
Endogastric Solutions Raises US$1 Million In Venture Financing 15
Endogastric Solutions Raises US$10 Million In Venture Financing 16
EndoGastric Solutions Inc – Key Competitors 17
EndoGastric Solutions Inc – Key Employees 18
EndoGastric Solutions Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Other Significant Developments 20
Oct 26, 2017: EndoGastric Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication Procedure 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Key Facts 2
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EndoGastric Solutions Inc, Deals By Therapy Area, 2011 to YTD 2017 8
EndoGastric Solutions Inc, Medical Devices Deals, 2011 to YTD 2017 9
EndoGastric Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
EndoGastric Solutions Raises USD50 Million in Financing Round 11
Endogastric Solutions Raises US$30 Million In Series G Venture Financing 13
Endogastric Solutions Raises US$1 Million In Venture Financing 15
Endogastric Solutions Raises US$10 Million In Venture Financing 16
EndoGastric Solutions Inc, Key Competitors 17
EndoGastric Solutions Inc, Key Employees 18

★海外企業調査レポート[EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sibur Holding:石油・ガス:M&Aディール及び事業提携情報
    Summary Sibur Holding (Sibur) is a vertically integrated gas processing and petrochemicals company. Sibur is one of the major players in Russian petrochemical industry delivering large volumes of associated petroleum gas. The company offers liquefied petroleum gas, natural gas, naphtha and natural g …
  • Audentes Therapeutics Inc (BOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Institute for Research in Immunology and Cancer-製薬・医療分野:企業M&A・提携分析
    Summary Institute for Research in Immunology and Cancer (IRICoR), a subsidiary of University of Montreal is a non-profit research institute that offers drug discovery and commercialization services. The institute offers discovery, development and commercialization of novel drugs in oncology. It has …
  • Concho Resources Inc.:企業の戦略・SWOT・財務情報
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • TRACON Pharmaceuticals Inc (TCON):企業の財務・戦略的SWOT分析
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TJ004309, TRC253, TRC694, and TRC205. Its le …
  • Douglas GmbH:企業の戦略・SWOT・財務情報
    Douglas GmbH - Strategy, SWOT and Corporate Finance Report Summary Douglas GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Baylor College of Medicine:企業のM&A・事業提携・投資動向
    Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baylor College of Medicine Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • TransUnion LLC:企業の戦略・SWOT・財務分析
    TransUnion LLC - Strategy, SWOT and Corporate Finance Report Summary TransUnion LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Samsung Securities Co., Ltd. (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務情報
    Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • N.V. Nuon Energy:企業の戦略・SWOT・財務情報
    N.V. Nuon Energy - Strategy, SWOT and Corporate Finance Report Summary N.V. Nuon Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mediq NV:企業の戦略的SWOT分析
    Mediq NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • NH Hotel Group, S. A. (NHH):企業の財務・戦略的SWOT分析
    NH Hotel Group, S. A. (NHH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Aimpoint AB:企業の戦略・SWOT・財務情報
    Aimpoint AB - Strategy, SWOT and Corporate Finance Report Summary Aimpoint AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Doosan Heavy Industries & Construction Co Ltd (034020):企業の財務・戦略的SWOT分析
    Doosan Heavy Industries & Construction Co Ltd (034020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Helen of Troy Ltd:企業の戦略・SWOT・財務情報
    Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report Summary Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ceska rafinerska, a.s.-石油・ガス分野:企業M&A・提携分析
    Summary Ceska rafinerska, a.s. (Ceska rafinerska) is a crude oil refining company. It carries out the refining of crude oil, and production of petroleum based products. The company’s product portfolio includes automobile gasoline, diesel oil, aviation fuel, fuel oils, liquefied petroleum gas, heatin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆